Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rettig

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center StudyIda Sonni, Matthias Eiber, Wolfgang P Fendler, et al.
Current Oncology Reports|February 1, 2023
Multimodality Therapies for Localized Prostate CancerLuca F Valle, Tommy Jiang, Adam B Weiner, et al.
Blood|April 1, 1996
VH gene usage is multiple myeloma: complete absence of the VH4.21 (VH4-34) geneM B Rettig, R A Vescio, J Cao, et al.
European Urology Oncology|November 9, 2025
Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical TrialRaag Agrawal, Adam B Weiner, Julie Livingstone, et al.
Science (New York, N.Y.)|June 20, 1997
Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patientsM B Rettig, H J Ma, R A Vescio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2025
Liquid Biopsy of Circulating Tumor Cells and DNA in the Context of PSMA Radiopharmaceutical TherapyAdrien Holzgreve, Christine E Mona, Koichiro Kimura, et al.
Cell Reports. Medicine|November 13, 2024
PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancersYiqian Gu, Ann Ly, Sara Rodriguez, et al.
Plos One|June 5, 2026
Deep learning models built from PSMA PET of the primary tumor can predict synchronous and metachronous prostate cancer metastasesJesus E Juarez Casillas, Maryam Nezafat, Cecil M Benitez, et al.
JAMA Network Open|December 1, 2023
Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate CancerTing Martin Ma, Neeraj Agarwal, Brandon Mahal, et al.
International Journal of Oncology|January 19, 2008
Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivoMaryam R Sartippour, Navindra P Seeram, Jian Yu Rao, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center StudyIda Sonni, Matthias Eiber, Wolfgang P Fendler, et al.
Current Oncology Reports|February 1, 2023
Multimodality Therapies for Localized Prostate CancerLuca F Valle, Tommy Jiang, Adam B Weiner, et al.
Blood|April 1, 1996
VH gene usage is multiple myeloma: complete absence of the VH4.21 (VH4-34) geneM B Rettig, R A Vescio, J Cao, et al.
European Urology Oncology|November 9, 2025
Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical TrialRaag Agrawal, Adam B Weiner, Julie Livingstone, et al.
Science (New York, N.Y.)|June 20, 1997
Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patientsM B Rettig, H J Ma, R A Vescio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2025
Liquid Biopsy of Circulating Tumor Cells and DNA in the Context of PSMA Radiopharmaceutical TherapyAdrien Holzgreve, Christine E Mona, Koichiro Kimura, et al.
Cell Reports. Medicine|November 13, 2024
PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancersYiqian Gu, Ann Ly, Sara Rodriguez, et al.
Plos One|June 5, 2026
Deep learning models built from PSMA PET of the primary tumor can predict synchronous and metachronous prostate cancer metastasesJesus E Juarez Casillas, Maryam Nezafat, Cecil M Benitez, et al.
JAMA Network Open|December 1, 2023
Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate CancerTing Martin Ma, Neeraj Agarwal, Brandon Mahal, et al.
International Journal of Oncology|January 19, 2008
Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivoMaryam R Sartippour, Navindra P Seeram, Jian Yu Rao, et al.
Pageof 15